{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T09:29:02Z","timestamp":1780824542409,"version":"3.54.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007595","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000}}],"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-15-0067"],"award-info":[{"award-number":["HDTRA1-15-0067"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1RO1AI114776"],"award-info":[{"award-number":["1RO1AI114776"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1F31AI136615-01"],"award-info":[{"award-number":["1F31AI136615-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM07863"],"award-info":[{"award-number":["T32 GM07863"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI007528"],"award-info":[{"award-number":["T32 AI007528"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007595","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T17:31:36Z","timestamp":1564421496000},"page":"e0007595","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":51,"title":["Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin"],"prefix":"10.1371","volume":"13","author":[{"given":"Evelyn M.","family":"Cov\u00e9s-Datson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dyall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Evans","family":"DeWald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Dube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly C.","family":"Drews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Gerhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Torzewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Postnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janie Y.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupal","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagathpala","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Jahrling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene G.","family":"Olinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0532-996X","authenticated-orcid":true,"given":"Judith M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Markovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Ebola virus disease [Internet]. 2019 [cited 26 May 2019]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ebola-virus-disease\" xlink:type=\"simple\">https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ebola-virus-disease<\/ext-link>"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.15585\/mmwr.su6503a2","article-title":"Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014\u20132016 Ebola Epidemic","volume":"65","author":"BP Bell","year":"2016","journal-title":"MMWR Suppl"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1614067","article-title":"Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia","volume":"377","author":"SB Kennedy","year":"2017","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial","volume":"315","author":"ID Milligan","year":"2016","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"AM Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"ref6","article-title":"Correlates of vaccine-induced protective immunity against Ebola virus disease","author":"D Medaglini","year":"2018","journal-title":"Semin Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(18)30560-9","article-title":"Questionable efficacy of the rVSV-ZEBOV Ebola vaccine","volume":"391","author":"WG Metzger","year":"2018","journal-title":"Lancet"},{"key":"ref8","article-title":"Integrating Clinical Research into Epidemic Response","year":"2017"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/d41586-018-05205-x","article-title":"Experimental drugs poised for use in Ebola outbreak","volume":"557","author":"E. Check Hayden","year":"2018","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"X Qiu","year":"2014","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea","volume":"13","author":"D Sissoko","year":"2016","journal-title":"PLOS Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"TK Warren","year":"2016","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"jiw496","DOI":"10.1093\/infdis\/jiw496","article-title":"Experimental Therapies for Ebola Virus Disease: What Have We Learned?","volume":"215","author":"FG Hayden","year":"2017","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrmicro1707","article-title":"Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy","volume":"5","author":"J. Balzarini","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/glycob\/cwn063","article-title":"Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers","volume":"18","author":"S-C Tao","year":"2008","journal-title":"Glycobiology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cell.2015.09.056","article-title":"Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity","volume":"163","author":"MD Swanson","year":"2015","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-3542(02)00183-3","article-title":"Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus","volume":"58","author":"LG Barrientos","year":"2003","journal-title":"Antiviral Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virol.2016.12.010","article-title":"Comparison of N\u2014and O -linked glycosylation patterns of ebolavirus glycoproteins","volume":"502","author":"AL Collar","year":"2017","journal-title":"Virology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/viro.1994.1147","article-title":"Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein","volume":"199","author":"H Feldmann","year":"1994","journal-title":"Virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/096876899294706","article-title":"Wiley DC. Structural basis for membrane fusion by enveloped viruses","volume":"16","author":"W Weissenhorn","year":"1999","journal-title":"Mol Membr Biol"},{"key":"ref21","unstructured":"Michelow IC, Lear C, Scully C, Prugar LI, Longley CB, Yantosca LM, et al. High-Dose Mannose-Binding Lectin Therapy for Ebola Virus Infection. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.1093\/infdis\/jiq025\" xlink:type=\"simple\">10.1093\/infdis\/jiq025<\/ext-link><\/comment>"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.1021\/acs.analchem.6b02334","article-title":"Combining Yeast Display and Competitive FACS to Select Rare Hapten-Specific Clones from Recombinant Antibody Libraries","volume":"88","author":"Y Sun","year":"2016","journal-title":"Anal Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e0166318","DOI":"10.1371\/journal.pone.0166318","article-title":"Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus","volume":"11","author":"Y Cong","year":"2016","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e0194880","DOI":"10.1371\/journal.pone.0194880","article-title":"Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs","volume":"13","author":"E Postnikova","year":"2018","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1128\/JVI.01272-14","article-title":"A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity","volume":"88","author":"A Watt","year":"2014","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/v8080206","article-title":"Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications","volume":"8","author":"EA Nelson","year":"2016","journal-title":"Viruses"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e0005540","DOI":"10.1371\/journal.pntd.0005540","article-title":"The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection","volume":"11","author":"EA Nelson","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref28","article-title":"Modeling the lifecycle of Ebola virus under biosafety level 2 conditions with virus-like particles containing tetracistronic minigenomes","author":"T Hoenen","year":"2014","journal-title":"J Vis Exp"},{"key":"ref29","article-title":"Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures","author":"J Dyall","year":"2018","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e56265","DOI":"10.1371\/journal.pone.0056265","article-title":"Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection","volume":"8","author":"CJ Shoemaker","year":"2013","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"190ra79","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection","volume":"5","author":"LM Johansen","year":"2013","journal-title":"Sci Transl Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"290ra89","DOI":"10.1126\/scitranslmed.aaa5597","article-title":"A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity","volume":"7","author":"LM Johansen","year":"2015","journal-title":"Sci Transl Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1086\/514292","article-title":"A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever","volume":"179","author":"M Bray","year":"1999","journal-title":"J Infect Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1074\/jbc.M109.034926","article-title":"A lectin isolated from bananas is a potent inhibitor of HIV replication","volume":"285","author":"MD Swanson","year":"2010","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.bmcl.2016.06.053","article-title":"Quinoxaline-based inhibitors of Ebola and Marburg VP40 egress","volume":"26","author":"HM Loughran","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(18)31710-0","article-title":"Prevention of Ebola virus disease through vaccination: where we are in 2018","volume":"392","author":"Y L\u00e9vy","year":"2018","journal-title":"Lancet (London, England)"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.ppat.1001098","article-title":"Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein","volume":"6","author":"JR Francica","year":"2010","journal-title":"PLoS Pathog."},{"key":"ref38","first-page":"1294","article-title":"Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection","volume":"6","author":"MD Tate","year":"2014","journal-title":"Viruses. Multidisciplinary Digital Publishing Institute (MDPI)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1128\/JVI.00406-16","article-title":"Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry","volume":"90","author":"EEH Tran","year":"2016","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e0124784","DOI":"10.1371\/journal.pone.0124784","article-title":"Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate","volume":"10","author":"E Stansell","year":"2015","journal-title":"PLoS One."},{"key":"ref41","first-page":"e1004731","article-title":"Ebola Virus Entry: A Curious and Complex Series of Events","volume":"11","author":"S Moller-Tank","year":"2015"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007595","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0007595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:02:15Z","timestamp":1588964535000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007595"}},"subtitle":[],"editor":[{"given":"Johan","family":"van Griensven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007595","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0007595","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]}}}